Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Greene

Showing results (331-340 of 410) with videos related to

Pageof 41
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2012
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) StudyAmanda Hyre Anderson, Wei Yang, Chi-yuan Hsu, et al.
Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis TrialLaura M Dember, James S Kaufman, Gerald J Beck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.
Kidney International|November 25, 2018
Deceased-donor acute kidney injury is not associated with kidney allograft failureIsaac E Hall, Enver Akalin, Jonathan S Bromberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 13, 2015
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKDLesley A Inker, Hocine Tighiouart, Josef Coresh, et al.
Kidney International|April 20, 2021
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathyDavid C Wheeler, Robert D Toto, Bergur V Stefánsson, et al.
The American Journal of Cardiology|March 1, 2026
The Effect of Vericiguat on Endothelial Function in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Randomized StudyKonstantinos Sideris, Kanokwan Bunsawat, Lina Brinker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 10, 2020
Drug Development in Kidney Disease: Proceedings From a Multistakeholder ConferenceDaniel L Edmonston, Matthew T Roe, Geoffrey Block, et al.
The Journal of Trauma and Acute Care Surgery|March 26, 2014
Decompressive craniectomy or medical management for refractory intracranial hypertension: an AAST-MIT propensity score analysisRam Nirula, D Millar, Tom Greene, et al.
Implementation Science : IS|February 1, 2020
QuitSMART Utah: an implementation study protocol for a cluster-randomized, multi-level Sequential Multiple Assignment Randomized Trial to increase Reach and Impact of tobacco cessation treatment in Community Health CentersMaria E Fernandez, Chelsey R Schlechter, Guilherme Del Fiol, et al.
Pageof 41

Showing results (331-340 of 410) with videos related to

Sort By:
Pageof 41
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2012
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) StudyAmanda Hyre Anderson, Wei Yang, Chi-yuan Hsu, et al.
Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis TrialLaura M Dember, James S Kaufman, Gerald J Beck, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.
Kidney International|November 25, 2018
Deceased-donor acute kidney injury is not associated with kidney allograft failureIsaac E Hall, Enver Akalin, Jonathan S Bromberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 13, 2015
GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKDLesley A Inker, Hocine Tighiouart, Josef Coresh, et al.
Kidney International|April 20, 2021
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathyDavid C Wheeler, Robert D Toto, Bergur V Stefánsson, et al.
The American Journal of Cardiology|March 1, 2026
The Effect of Vericiguat on Endothelial Function in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Randomized StudyKonstantinos Sideris, Kanokwan Bunsawat, Lina Brinker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 10, 2020
Drug Development in Kidney Disease: Proceedings From a Multistakeholder ConferenceDaniel L Edmonston, Matthew T Roe, Geoffrey Block, et al.
The Journal of Trauma and Acute Care Surgery|March 26, 2014
Decompressive craniectomy or medical management for refractory intracranial hypertension: an AAST-MIT propensity score analysisRam Nirula, D Millar, Tom Greene, et al.
Implementation Science : IS|February 1, 2020
QuitSMART Utah: an implementation study protocol for a cluster-randomized, multi-level Sequential Multiple Assignment Randomized Trial to increase Reach and Impact of tobacco cessation treatment in Community Health CentersMaria E Fernandez, Chelsey R Schlechter, Guilherme Del Fiol, et al.
Pageof 41